Emerging Trends Influencing The Growth Of The Opioid Use Disorder (OUD) Market: FDA Approval Of Brixadi Marks A Milestone In Opioid Use Disorder (OUD) Market Through Innovative Treatment Options

The Opioid Use Disorder (OUD) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Opioid Use Disorder (OUD) Market Size Expected to Be by 2034?
The market for opioid use disorder (OUD) has experienced significant expansion in the recent past. It is projected to increase from $3.96 billion in 2024 to $4.39 billion in 2025, representing a compound annual growth rate (CAGR) of 10.9%. The upturn during the historic phase is largely due to factors such as higher prescription rates, improved pain management tactics, advances in drug marketing, and the stigma associated with addiction.

The market size for opioid use disorder (OUD) is predicted to experience a swift increase in the coming years. It will ascend to a valuation of $6.94 billion in 2029, with a compound annual growth rate (CAGR) of 12.1%. Factors attributing to this projected growth within the forecasted period include regulatory actions, concentration on alternate pain management, expansion in treatment accessibility, and public health initiatives. Significant trends to foresee during this period encompass advancements in treatment technology, personalized treatment strategies, comprehensive care frameworks, support programs based in the community, along with the emphasis on early intervention and prevention.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

What Are the Emerging Segments Within the Opioid Use Disorder (OUD) Market?
The opioid use disorder (OUD) market covered in this report is segmented -

1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Long-Term Drivers Are Shaping Opioid Use Disorder (OUD) Market Trends?
The rise in incidents of opioid addiction is projected to boost the expansion of the opioid use disorder (OUD) market. A medical situation identified by compulsive, chronic use of opioids with damaging effects on the body is what we refer to as opioid addiction. Opioids can provide a feeling of ecsta*sy and relieve pain; however, continuous use can result in tolerance, needing larger doses for the same maximal outcome, which could potentially cause an opioid use disorder. For example, the Centers for Disease Control and Prevention, a US public health agency, reported in March 2024 that the overdosage rate of synthetic opioid drugs saw a 4.1% rise, escalating from 21.8 to 22.7 between 2021 and 2022. As a result, the surge in opioid addiction cases is fuelling the growth of the opioid use disorder (OUD) market.

Who Are the Top Competitors in Key Opioid Use Disorder (OUD) Market Segments?
Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

What Opioid Use Disorder (OUD) Market Trends Are Gaining Traction Across Different Segments?
The creation of new products is becoming a significant trend in the opioid use disorder (OUD) market. The major companies involved in the OUD market are focusing on bringing innovative products to the market in order to maintain their standing. For example, the U.S. Food and Drug Administration, a federal agency from the United States, gave the green light for Brixadi (buprenorphine) extended-release injection in May 2023. This injection is used to manage moderate to severe opioid use disorder (OUD) and is offered in two dosage formats. One is a weekly injection for patients who initiated treatment with a single transmucosal buprenorphine product dose or who are currently on medication, and the other is a monthly variant for patients who are already using this medication.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Which Regions Are Becoming Hubs for Opioid Use Disorder (OUD) Market Innovation?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Opioid Use Disorder (OUD) Market?
2. What is the CAGR expected in the Opioid Use Disorder (OUD) Market?
3. What Are the Key Innovations Transforming the Opioid Use Disorder (OUD) Industry?
4. Which Region Is Leading the Opioid Use Disorder (OUD) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.